Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Clinical Trial Based on Standard Treatment to Evaluate the Effect of Injectable Neucardin on Cardiac Function and Reverse Ventricular Remodeling in Patients With Chronic Systolic Heart Failure

NCT05949801 is registered in ClinicalTrials.gov with Zensun Sci. & Tech. Co., Ltd. as lead sponsor.

NCT NCT05949801
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05949801 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Clinical Trial Based on Standard Treatment to Evaluate the Effect of Injectable Neucardin on Cardiac Function and Reverse Ventricular Remodeling in Patients With Chronic Systolic Heart Failure
Lead sponsor
Zensun Sci. & Tech. Co., Ltd.
Phase
Phase 3
Overall status
Completed
Start date
April 13, 2023
Completion date
October 14, 2024
Enrollment
202 (actual)
Sites
103

Conditions

As the registry lists them; a condition with its own page is linked.

chronic systolic heart failure